Literature DB >> 18598744

Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A.

Florian Thieringer1, Thorsten Maass, Piotr Czochra, Borut Klopcic, Ilka Conrad, Diana Friebe, Peter Schirmacher, Ansgar W Lohse, Manfred Blessing, Peter R Galle, Andreas Teufel, Stephan Kanzler.   

Abstract

Platelet derived growth factor (PDGF) plays a central role in repair mechanisms after acute and chronic tissue damage. To further evaluate the role of PDGF-A in liver fibrogenesis in vivo, we generated transgenic mice with hepatocyte-specific overexpression of PDGF-A using the CRP-gene promoter. Transgenic but not wildtype mice showed expression of PDGF-A mRNA in the liver. Hepatic PDGF-A overexpression was accompanied by a significant increase in hepatic procollagen III mRNA expression as well as TGF-beta1 expression. Liver histology showed increased deposition of extracellular matrix in transgenic but not in wildtype mice. PDGF-A-transgenic mice showed positive sinusoidal staining for alpha-SMA indicating an activation of hepatic stellate cells. Since the profibrogenic effect of PDGF-A was accompanied by increased TGF-beta1 protein concentration in the liver of transgenic mice, it can be postulated that PDGF-A upregulates expression of TGF-beta1 which is a strong activator of hepatic stellate cells. Thus, these results point towards a fibrosis induction by PDGF-A via the TGF-beta1 signalling pathway. In conclusion, expression and functional analysis of PDGF-A in the liver of transgenic mice suggest a relevant profibrogenic role of PDGF-A via TGF-beta1 induction. Counteracting PDGF-A may therefore be one of the effects of tyrosine kinase inhibitors which showed protective effects in animal models of liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598744     DOI: 10.1016/j.gene.2008.05.022

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  18 in total

1.  Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

Authors:  Naga Chalasani; Xiuqing Guo; Rohit Loomba; Mark O Goodarzi; Talin Haritunians; Soonil Kwon; Jinrui Cui; Kent D Taylor; Laura Wilson; Oscar W Cummings; Yii-Der Ida Chen; Jerome I Rotter
Journal:  Gastroenterology       Date:  2010-08-11       Impact factor: 22.682

Review 2.  PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer.

Authors:  Alexander Kikuchi; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2015

3.  Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.

Authors:  Junji Ma; Yuzi Qiu; Min Wang; Ming Zhang; Xiaoyi Zhao; Huiqing Jiang
Journal:  Dig Dis Sci       Date:  2019-03-14       Impact factor: 3.199

Review 4.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 5.  Toll-like receptors, wound healing, and carcinogenesis.

Authors:  Johannes Kluwe; Ali Mencin; Robert F Schwabe
Journal:  J Mol Med (Berl)       Date:  2008-12-17       Impact factor: 4.599

Review 6.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

7.  Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.

Authors:  Jocelyn H Wright; Melissa M Johnson; Masami Shimizu-Albergine; Renay L Bauer; Brian J Hayes; James Surapisitchat; Kelly L Hudkins; Kimberly J Riehle; Simon C Johnson; Matthew M Yeh; Theodor K Bammler; Richard P Beyer; Debra G Gilbertson; Charles E Alpers; Nelson Fausto; Jean S Campbell
Journal:  Int J Cancer       Date:  2013-09-16       Impact factor: 7.396

8.  Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.

Authors:  Jung Il Lee; Jocelyn H Wright; Melissa M Johnson; Renay L Bauer; Kristina Sorg; Sebastian Yuen; Brian J Hayes; Lananh Nguyen; Kimberly J Riehle; Jean S Campbell
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-02       Impact factor: 4.249

9.  Age and ethnicity in cirrhosis.

Authors:  Krishna C Sajja; Desh P Mohan; Don C Rockey
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

10.  Targeting the PDGF signaling pathway in the treatment of non-malignant diseases.

Authors:  Carl-Henrik Heldin
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-25       Impact factor: 7.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.